<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>https://wechat.privacyhide.com/</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 23 Jan 2021 20:33:30 +0800</pubDate><image><url>http://wx.qlogo.cn/mmhead/Q3auHgzwzM6S32nesXE5WMXQf96prfn8CKpR5A7icW1FMJegVQwIrUQ/64</url><title>医麦客 | wechat-feeds</title><link>https://wechat.privacyhide.com/</link><width>64</width><height>64</height></image><item><title>治疗卒中，呈诺医学iPSC来源EPC细胞产品ALF201临床申请获国家药监局受理丨医麦猛爆料​</title><link>https://mp.weixin.qq.com/s/b97WRVY-si7EU_I58OR7rw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIurhn2ibt3q1ic4iaXphh1nh5MOySBBz01CKQuicnzScK7QL5pxqiaItCjnGfqh0FzCficUn4rvMhxWadxA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首个即将进入临床的iPSC技术衍生的功能细胞药物产品]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:41:32 +0800</pubDate></item><item><title>年初买买买！这家初创TIL公司为何值得被看好？丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/IHLDdS2PjfYWsH3fdqNyCQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItvsZN4NRbkHF2U8Jxbibdnltj4ERengUictdeia6MXWqOJv5OFtWKiagMcFg3OK4Sfj0YKK9N4Uibt5ibQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>溶瘤病毒与TIL细胞疗法的结合]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:41:32 +0800</pubDate></item><item><title>国内首个CD20 CAR-T细胞获得临床默示许可丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/nC04OnLwsYOLzOISBhj54g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItvsZN4NRbkHF2U8JxbibdnlVPyy83RCibjLyCdictr4nBx6dBN4icwU009b8vbULs1w4fx0ic4ZFG0cGA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>下一个热门靶点：CD20]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:41:32 +0800</pubDate></item><item><title>药融资丨CDMO公司Northway投资4000万美元在大波士顿设立工厂，扩大包括新冠治疗策略在内的生物制剂产能</title><link>https://mp.weixin.qq.com/s/WED0f66h-DokQX24skdmiw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItvsZN4NRbkHF2U8JxbibdnlG6vhSnTUltFDViaHXk6dRzJJSbI8xMCEiaPHUdrcYSDGgiblb2g05X7tw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>4个月的新冠开发合作展现迅速响应能力]]></content:encoded><pubDate>Fri, 22 Jan 2021 19:41:32 +0800</pubDate></item><item><title>国内首个CAR-T疗法即将上市，成功的关键是什么？丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/m936tvfhbcHuaH1AWaGQ7g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIurhn2ibt3q1ic4iaXphh1nh5MORxaXQ1JPtlzwojUgdthltspMBgGHDGpsyDGAAviaVKPNNVpxH8KjzA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T疗法呈现出“百花争艳”的局面。]]></content:encoded><pubDate>Thu, 21 Jan 2021 22:22:00 +0800</pubDate></item><item><title>赠书 | 当进行除病毒过滤验证，需要关注什么？</title><link>https://mp.weixin.qq.com/s/msn7vZWbw3CiDCrevMbfaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIurhn2ibt3q1ic4iaXphh1nh5M2BJJEoPHZpicM7LBNLtBvibYK5SRNuJyS6RkOibMJfmgebU4aKIsNo92w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>快来领你想要的《治疗用生物制品病毒污染风险控制要点》]]></content:encoded><pubDate>Thu, 21 Jan 2021 22:22:00 +0800</pubDate></item><item><title>包含五种转基因的溶瘤性单纯疱疹病毒，临床前数据显示出强大的全身性抗肿瘤活性丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/AheSOoieFRr96nSLjKVM2w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIurhn2ibt3q1ic4iaXphh1nh5M5RbPaiaJkDEUeK7gvr4ZXkPLTxhbndlagtXj603yIIaliaWY8TrGib9uw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>保留基因γ34.5的oHSV在抗病毒环境中拥有较强的复制能力]]></content:encoded><pubDate>Thu, 21 Jan 2021 22:22:00 +0800</pubDate></item><item><title>药融资丨天演药业递交赴美上市申请，拟募资1.25亿美元</title><link>https://mp.weixin.qq.com/s/ap_wXH6JGrOOP5wQgm5Exg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIurhn2ibt3q1ic4iaXphh1nh5MPjSjb2V3La2QQSmMx3MSSbsnEKXmWY3X500Wib5PwpzoctAh23FnuiaA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>累计募资超十亿人民币]]></content:encoded><pubDate>Thu, 21 Jan 2021 22:22:00 +0800</pubDate></item><item><title>医药产业发展新浪潮（下）——细胞和基因疗法研发生产外包服务</title><link>https://mp.weixin.qq.com/s/ce9i3IK_UsgjkFEUvhPSpg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/Ay0etx2tNQmfuWxVjpOWCClfcMU6fWhstRqmrLjm5FYCibIPFAhtV48khGuY0eE4RYXYrrNLgxd3UcaBLGibqfcg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内细胞和基因疗法热度显现，龙头企业纷纷布局]]></content:encoded><pubDate>Wed, 20 Jan 2021 17:12:37 +0800</pubDate></item><item><title>亘喜生物基于FasTCAR平台开发的针对复发或难治性B-ALL成年患者的GC019F CAR-T获得IND批准进入注册临床研究</title><link>https://mp.weixin.qq.com/s/drQbMFJg-OcpYTUHhICPpw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuibticFw7O6sR9L0nbmdzvce0KLpKyrDWFeWEP7h55WHp0KVqZLgzyeYwbicMia6AcbibdBicOlSxKgXpg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>亘喜生物FasTCAR平台生产的候选产品首次获得IND批准]]></content:encoded><pubDate>Wed, 20 Jan 2021 17:12:37 +0800</pubDate></item><item><title>恒润达生CAR-T细胞治疗迈向产业化，欧盟标准生产基地正式落成丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Kk0Y6rpQqdHZMTITV-l1Jw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuibticFw7O6sR9L0nbmdzvce1R9W2tuDcNgJpDaB1CN0zoqVHlFU1h9bHEGoOWz5ia4t0dNDljasIMw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>恒润达生细胞制备中心正式落成]]></content:encoded><pubDate>Wed, 20 Jan 2021 17:12:37 +0800</pubDate></item><item><title>“递送策略”革新之干细胞篇丨医麦新观察</title><link>https://mp.weixin.qq.com/s/4JQEAz_nBV2LNs5l1XhB0g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuibticFw7O6sR9L0nbmdzvcePwu8X53REDib3ibN3oH0EfEcON86uKTugyfQRRYc76ribadgiaXexs5r3Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>用作药物递送载体或本身作为一种治疗手段]]></content:encoded><pubDate>Wed, 20 Jan 2021 17:12:37 +0800</pubDate></item><item><title>药融资丨Immunocore拟募资1亿美元IPO，推进TCR疗法</title><link>https://mp.weixin.qq.com/s/mpkxC1vlyhc7dt6_W-3-bg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mW6rQAOYFI6qEZmaaJSIkJrMqUpLjUKqCTibFDbIXHaeGC21vWpaVhH1o1EicqE5r6Zc6Br2iasISURZL7G8EgUPg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>几天前刚刚完成了7500万美元的C轮融资]]></content:encoded><pubDate>Wed, 20 Jan 2021 17:12:37 +0800</pubDate></item><item><title>医药产业发展新浪潮（上）——细胞和基因疗法</title><link>https://mp.weixin.qq.com/s/dtUTXA6B9E2UvZjSMvpDCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIusia3SbDnu0DeLibicEHGFcZK8q2NcGu3bbqROt4RvFu0PuqTUzkIkJFXdptDkMUFH9bsnopmNng3Jg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CGT疗法未来可期]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>纽福斯与AAVnerGene就新一代眼科基因治疗AAV载体技术建立全球战略合作伙伴关系丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/dWyDskWNUGhsSPtCEgDutw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvqFKC6o8ibDnM2oS61nc0Tlm5kvzwVMabHtCtF2iblL5JQyiaic6pAUEetabX6SoSNqTp2gsgMMTdYAw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新一代AAV载体有望通过提高转染率和特异性]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>Nature子刊：瘫痪小鼠重新行走，AAV基因疗法潜力无限丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/VfLfE2eDuzN_5o3QoVc0kA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvqFKC6o8ibDnM2oS61nc0TlZpAABfQiavxXYczkmsAfAldTXPvhTUW2290hkvMEBRDk60s9wy59lzg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>神经元再生策略]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>斥资逾16亿美元，礼来这次看上双特异性抗体领域丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/J3g5JlWvDqPZI8RZOo8nug</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvqFKC6o8ibDnM2oS61nc0TluSwDFxSRzibicnp9hX75YhgCB9XrKoqdXtQyzD7fEcPqeeglOUhiaGiaMA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>礼来接连斥巨资完成多项合作和收购，涉及基因治疗、RNAi疗法、外泌体技术等多个创新技术领域]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>药融资丨Vor拟募资1.5亿美元IPO，推进CD33 CAR-T疗法</title><link>https://mp.weixin.qq.com/s/I6C1loVGOyNmpTjxYMPxDQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvqFKC6o8ibDnM2oS61nc0TluJQgl1Kiab2GPte2nEU1YVnLnrfxMUHkMic7ynHGxJJ42ATLhLic07HWg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>拥有强大潜力的工程造血干细胞（eHSC）]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>武汉友芝友生物CD38/CD3双抗获临床默示许可，系国内首款丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/x9Q5hkik3xApv0dfSc5d_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/jn7Grkxp8cibF7q2Y86pOzqBavz8n00TiaEjQeYic4ZLb7RDUfwhWTEcbOICdarS2Zoiblgv6M01wrySXoqiawW5ASQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CD38研发正当时！]]></content:encoded><pubDate>Tue, 19 Jan 2021 23:04:15 +0800</pubDate></item><item><title>治疗结直肠癌，全球首个非基因编辑的同种异体CAR-T临床项目公布1期临床结果丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/zpIxyG0iiiFNegxA5Nxi_Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvqFKC6o8ibDnM2oS61nc0TlWwIV4JSlzVpcFYzBeVlzOdCibQjNYiabsKPcpLEbgMgv5TZcaGHPqgTg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>通用型是CAR-T疗法的未来]]></content:encoded><pubDate>Tue, 19 Jan 2021 11:50:04 +0800</pubDate></item></channel></rss>